Medibank Private Ltd. has returned +46.3% from $1.90 since 2021, trailing SPY's +70.5% over the same period. The stock hit an all-time high of $3.30 in Oct 2025 and is currently 15.8% below that level. Of 7 tracked news events, 43% produced a positive market-adjusted return.
Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.
Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.
Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.
Want the full written briefing?
The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.
| Date | Return | Category | Source | Headline |
|---|---|---|---|---|
| 2026-04-07 | -2.6% | analyst | The Globe and Mail | UBS Reaffirms Their Hold Rating on Medibank Private (MDBPF) - The Globe and Mail |
| 2025-11-19 | +1.1% | analyst | Seeking Alpha | Medibank Private Limited (MDBPF) Shareholder/Analyst Call Transcript |
| 2025-10-29 | +1.1% | news | Seeking Alpha | Medibank Private Limited (MDBPF) Discusses Health Business Growth Strategy and Long-Term Aspirations Transcript |
| 2025-10-29 | +1.1% | news | Seeking Alpha | Medibank Private Limited (MDBPF) Discusses Health Business Growth Strategy and Long-Term Aspirations - Slideshow |
| 2026-04-06 | -0.5% | analyst | Moomoo | UBS Maintains MEDIBANK PRIVATE LIMITED(MDBPF.US) With Hold Rating, Raises Target Price to $3.43 - Moomoo |
| 2026-02-19 | -0.5% | earnings | Seeking Alpha | Medibank Private Limited (MDBPF) Q2 2026 Earnings Call Transcript |
| 2026-04-26 | -0.2% | news | MSN | MSN Money - MSN |